Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.462 USD | +0.33% | -8.43% | -73.12% |
Business Summary
Number of employees: 18
Managers
Managers | Title | Age | Since |
---|---|---|---|
Donald Picker
FOU | Founder | 78 | 27/07/15 |
Walter Klemp
CEO | Chief Executive Officer | 64 | 27/07/15 |
Jonathan Foster
DFI | Director of Finance/CFO | 60 | 21/08/16 |
Chief Tech/Sci/R&D Officer | 71 | - | |
Sandra Silberman
CTO | Chief Tech/Sci/R&D Officer | 69 | 07/11/17 |
Dennis McNamara
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Walter Klemp
CEO | Chief Executive Officer | 64 | 27/07/15 |
Michael Cannon
BRD | Director/Board Member | 78 | 30/06/15 |
John Climaco
BRD | Director/Board Member | 55 | 23/07/17 |
Elizabeth Cermak
BRD | Director/Board Member | 66 | 01/10/20 |
Robert George
BRD | Director/Board Member | 74 | 30/06/15 |
Joy Yan
BRD | Director/Board Member | 44 | 28/02/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,311,536 | 2,200,425 ( 95.19 %) | 0 | 95.19 % |
Company contact information
Moleculin Biotech, Inc.
5300 Memorial Drive Suite 950
77007, Houston
+(713) 300-5160
http://www.moleculin.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-73.12% | 7.97M | |
+16.80% | 122B | |
+19.99% | 115B | |
+21.22% | 26.64B | |
-23.18% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-18.71% | 15.49B | |
+61.31% | 14.83B | |
+3.54% | 13.67B |
- Stock Market
- Equities
- MBRX Stock
- Company Moleculin Biotech, Inc.